These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2304580)

  • 21. [Anaphylaxis following administration of polidocanol].
    Jagtman BA; Balmus KJ
    Ned Tijdschr Geneeskd; 1990 Apr; 134(17):872. PubMed ID: 1692610
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of sclerotherapy in varicose veins-- prospective, blinded, placebo-controlled study.
    Kahle B; Leng K
    Dermatol Surg; 2004 May; 30(5):723-8; discussion 728. PubMed ID: 15099314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaphylactoid reaction after the use of sodium tetradecyl sulfate: a case report.
    Brzoza Z; Kasperska-Zajac A; Rogala E; Rogala B
    Angiology; 2007; 58(5):644-6. PubMed ID: 18024951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
    Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
    Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible neurological deficit after foam sclerotherapy.
    Hartmann K; Harms L; Simon M
    Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):648-9. PubMed ID: 19683463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Embolia cutis medicamentosa of the foot after sclerotherapy.
    Geukens J; Rabe E; Bieber T
    Eur J Dermatol; 1999 Mar; 9(2):132-3. PubMed ID: 10066964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of rectal varices treated with endoscopic injection sclerotherapy].
    Zeniya A; Odashima M; Takahashi H; Ohkubo S; Masamune O
    Nihon Shokakibyo Gakkai Zasshi; 1997 Jan; 94(1):38-43. PubMed ID: 9028142
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of sclerotherapy in abnormal varicose hand veins.
    Duffy DM; Garcia C; Clark RE
    Plast Reconstr Surg; 1999 Oct; 104(5):1474-9; discussion 1480-1. PubMed ID: 10513934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sclerotherapy--translucidation of the skin prior to injection.
    Scarborough DA; Bisaccia E
    J Dermatol Surg Oncol; 1989 May; 15(5):498-9. PubMed ID: 2715482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
    Cameron E
    Dermatol Surg; 2012 Feb; 38(2):290. PubMed ID: 22309639
    [No Abstract]   [Full Text] [Related]  

  • 32. Regarding "Stroke after varicose vein foam injection sclerotherapy".
    Eckmann DM; Kobayashi S
    J Vasc Surg; 2006 Jul; 44(1):225; author reply 225-6. PubMed ID: 16828455
    [No Abstract]   [Full Text] [Related]  

  • 33. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
    Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB
    Trials; 2014 Dec; 15():497. PubMed ID: 25527165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation.
    Marrocco-Trischitta MM; Guerrini P; Abeni D; Stillo F
    Dermatol Surg; 2002 Feb; 28(2):153-5. PubMed ID: 11860427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regarding "Stroke after varicose vein foam injection sclerotherapy".
    Morrison N; Cavezzi A; Bergan J; Partsch H
    J Vasc Surg; 2006 Jul; 44(1):224-5; author reply 225-6. PubMed ID: 16828453
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foam sclerotherapy for spouting haemorrhage in patients with varicose veins.
    Hamahata A; Yamaki T; Osada A; Fujisawa D; Sakurai H
    Eur J Vasc Endovasc Surg; 2011 Jun; 41(6):856-8. PubMed ID: 21420881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclerotherapy: review of results and complications in 200 patients.
    Puissegur Lupo ML
    J Dermatol Surg Oncol; 1989 Feb; 15(2):214-9. PubMed ID: 2915088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerotherapy in an undetected pregnancy - a catastrophe?
    Reich-Schupke S; Leiste A; Moritz R; Altmeyer P; Stücker M
    Vasa; 2012 Jul; 41(4):243-7. PubMed ID: 22825857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins.
    Darke SG; Baker SJ
    Br J Surg; 2006 Aug; 93(8):969-74. PubMed ID: 16739097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.